Michele Moschetta
Oncology R&D
Cambridge, ENG, United Kingdom
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
Randomized controlled trial of bromelain and alpha-lipoic acid in breast conservative surgery.
Journal: Scientific reports
Published: September 14, 2024
A phase Ib study of the combination of naporafenib with rineterkib or trametinib in patients with advanced and metastatic KRAS- or BRAF-mutant non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: June 04, 2024
Immunotherapy Combined With Standard Therapies in Head and Neck Squamous Cell Carcinoma - A Meta-analysis.
Journal: Anticancer research
Published: January 30, 2024
First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations.
Journal: European journal of cancer (Oxford, England : 1990)
Published: October 02, 2023
Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer-A Retrospective UK Single-Centre Study.
Journal: Cancers
Published: July 17, 2023
Diagnostic biomarkers in ovarian cancer: advances beyond CA125 and HE4.
Journal: Therapeutic advances in medical oncology
Published: April 05, 2023
Initial Evidence for the Efficacy of Naporafenib in Combination With Trametinib in NRAS-Mutant Melanoma: Results From the Expansion Arm of a Phase Ib, Open-Label Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 22, 2023
Melanoma-the therapeutic considerations in the clinical practice.
Journal: Annals of palliative medicine
Published: December 23, 2022
Immunotherapy for advanced urothelial carcinoma (UC): rational and current evidence.
Journal: Annals of palliative medicine
Published: November 26, 2022
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical Development.
Journal: Cancer discovery
Published: November 11, 2022
Advances in Ovarian Cancer Treatment Beyond PARP Inhibitors.
Journal: Current cancer drug targets
Published: October 24, 2022
Last Updated: 09/26/2026